Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: HIV contamination of commercial PCR enzymes raises the importance of quality control of low-cost in-house genotypic HIV drug resistance tests, Antiviral Therapy, January 2010, International Medical Press,
DOI: 10.3851/imp1478.
You can read the full text:
Contributors
The following have contributed to this page
